Pharmaceuticals, Biotechnology and Life Sciences
Basilea Pharmaceutica International has amended its existing license agreement for Europe, Russia, Turkey and Israel with Pfizer Inc. for Basilea’s…
STA Pharmaceutical (STA) – a China-based global API and Drug Product CDMO – reports that it has seen a rapid…
ViiV Healthcare on Thursday announced the start of HPTN 084,a phase III study to evaluate long-acting cabotegravir for the prevention of…
Novartis has announced first-of-its-kind long-term data showing that Cosentyx (secukinumab) provided sustained improvements in nail and palmoplantar psoriasis out to…
N4 Pharma, a specialist pharmaceutical company which reformulates existing drugs and vaccines to improve their performance, welcomes the announcement of the…
Circassia Pharmaceuticals welcomes the publication of new clinical guidelines by the UK’s National Institute for Health and Care Excellence (NICE),…
Oxford Pharmascience has gotten pre-IND scientific advice from the US regulatory drugs and foods authority about the development programme requirements likely…
Sanofi said on Wednesday it would ask health authorities to update information provided to physicians and patients on its dengue…
TopiVert Pharma, a clinical-stage biotechnology company developing Narrow Spectrum Kinase Inhibitors (NSKIs) for chronic inflammatory gastrointestinal (GI) and ocular diseases,…
The European Medicines Agency has accepted a variation to the Marketing Authorisation Application (MAAv) for Tagrisso (osimertinib) from Astrazeneca.